Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection.

[1]  Daniel G. Anderson,et al.  Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. , 2008, Cell host & microbe.

[2]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[3]  Jared T. Shaw,et al.  Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. , 2008, Biochemistry.

[4]  D. Praticò,et al.  Increased Oxidative Stress in Scavenger Receptor BI Knockout Mice With Dysfunctional HDL , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Michael S. Goldberg,et al.  Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway , 2007, Nature.

[6]  M. Mota,et al.  Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry , 2007, Cellular microbiology.

[7]  M. Mota,et al.  Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria , 2007, Nature Medicine.

[8]  D. Arnot,et al.  Rapid and specific biotin labelling of the erythrocyte surface antigens of both cultured and ex-vivo Plasmodium parasites , 2007, Malaria Journal.

[9]  C. Boucheix,et al.  Alternative invasion pathways for Plasmodium berghei sporozoites. , 2007, International journal for parasitology.

[10]  D. Malide,et al.  CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells , 2006, Proceedings of the National Academy of Sciences.

[11]  Ana Rodriguez,et al.  The silent path to thousands of merozoites: the Plasmodium liver stage , 2006, Nature Reviews Microbiology.

[12]  Nir Hacohen,et al.  Minimizing the risk of reporting false positives in large-scale RNAi screens , 2006, Nature Methods.

[13]  M. Mota,et al.  Antimalarial drugs – host targets (re)visited , 2006, Biotechnology journal.

[14]  Q. Bassat,et al.  Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial , 2005, The Lancet.

[15]  Norbert Perrimon,et al.  Drosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection , 2005, Science.

[16]  Chris J Janse,et al.  A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. , 2004, Molecular and biochemical parasitology.

[17]  A. Rigotti,et al.  Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism* , 2003, Journal of Biological Chemistry.

[18]  L. Falstrault,et al.  The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters. , 2003, Biochemistry.

[19]  R. Cortese,et al.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus , 2002, The EMBO journal.

[20]  D. Silver.  A Carboxyl-terminal PDZ-interacting Domain of Scavenger Receptor B, Type I Is Essential for Cell Surface Expression in Liver* , 2002, The Journal of Biological Chemistry.

[21]  B. Greenwood,et al.  Malaria in 2002 , 2002, Nature.

[22]  M. Tsuji,et al.  Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. , 2001, International journal for parasitology.

[23]  M. Mota,et al.  Migration of Plasmodium sporozoites through cells before infection. , 2001, Science.

[24]  M. Krieger,et al.  Dissociation of the High Density Lipoprotein and Low Density Lipoprotein Binding Activities of Murine Scavenger Receptor Class B Type I (mSR-BI) Using Retrovirus Library-based Activity Dissection* , 2000, The Journal of Biological Chemistry.

[25]  M. Shakibaei,et al.  Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans , 1996, The Journal of experimental medicine.

[26]  V. Nussenzweig,et al.  Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes , 1996, The Journal of experimental medicine.

[27]  D. Mazier,et al.  Complete development of hepatic stages of Plasmodium falciparum in vitro. , 1985, Science.

[28]  M. Tsuji,et al.  Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites , 2004, Parasitology Research.

[29]  S. Levy,et al.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity , 2003, Nature Medicine.